Saturday 17 October 2026
Export A’s income statement to Excel — free account
Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
172.96
2.59
−1.48%
Follow A
| Oct '16 | Oct '17 | Oct '18 | Oct '19 | Oct '20 | Oct '21 | Oct '22 | Oct '23 | Oct '24 | Oct '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
30.90 | 31.94 | 64.79 | 22.35 | 45.17 | 39.46 | 32.94 | 24.50 | 29.35 | 31.96 |
Piotroski F-Score |
8 | 8 | 7 | 5 | 5 | 7 | 7 | 6 | 5 | 5 |
P/S ratio |
3.38 | 4.90 | 4.23 | 4.61 | 6.09 | 7.56 | 6.04 | 4.45 | 5.80 | 5.98 |
Altman Z-Score |
4.71 | 4.90 | 4.39 | 4.05 | 5.08 | 6.69 | 6.17 | 5.15 | 5.07 | 5.46 |
Altman Z″-Score (non-manufacturers) |
6.60 | 4.27 | 3.85 | 2.49 | 3.02 | 3.30 | 3.39 | 3.90 | 3.23 | 3.48 |
P/FCF ratio |
21.72 | 30.72 | 22.83 | 27.47 | 40.50 | 36.87 | 40.64 | 20.66 | 27.58 | 36.02 |
Beneish M-Score |
(2.64) | (2.47) | (2.79) | (2.24) | (2.48) | (2.49) | (2.34) | (2.72) | (2.64) | (2.46) |
P/Operating CF |
60.70 | 76.06 | 55.91 | 75.75 | 86.26 | 108.27 | 92.34 | 58.90 | 78.57 | 76.27 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 86 |
P/B ratio |
3.35 | 4.53 | 4.55 | 5.01 | 6.67 | 8.86 | 7.80 | 5.20 | 6.41 | 6.17 |
Price to Tangible BV |
10.82 | 11.73 | 18.79 | 495.53 | 73.91 | 110.27 | 77.76 | 21.55 | 43.24 | 22.80 |
EV/Sales |
3.29 | 4.70 | 4.14 | 4.69 | 6.25 | 7.74 | 6.29 | 4.62 | 6.11 | 6.16 |
EV/EBITDA |
16.05 | 20.64 | 18.27 | 20.52 | 28.91 | 29.32 | 22.25 | 19.45 | 22.81 | 24.24 |
EV/Operating CF |
17.43 | 23.65 | 18.72 | 23.70 | 36.22 | 32.93 | 32.81 | 17.80 | 22.73 | 27.47 |
EV/FCF |
21.13 | 29.49 | 22.34 | 27.94 | 41.55 | 37.76 | 42.29 | 21.44 | 29.06 | 37.11 |
Quick Ratio |
3.09 | 2.69 | 2.58 | 1.11 | 1.69 | 1.61 | 1.32 | 1.80 | 1.40 | 1.40 |
Current Ratio |
3.85 | 3.30 | 3.29 | 1.53 | 2.33 | 2.22 | 2.03 | 2.61 | 2.09 | 1.96 |
Net Debt/EBITDA |
(0.45) | (0.86) | (0.40) | 0.35 | 0.73 | 0.69 | 0.87 | 0.71 | 1.16 | 0.71 |
Debt/Assets |
24.43% | 21.37% | 21.06% | 18.95% | 23.72% | 25.49% | 25.95% | 25.41% | 28.24% | 23.96% |
Debt/Equity |
0.45 | 0.37 | 0.39 | 0.38 | 0.47 | 0.51 | 0.52 | 0.47 | 0.57 | 0.45 |
Asset Turnover |
0.55 | 0.55 | 0.58 | 0.57 | 0.56 | 0.62 | 0.64 | 0.64 | 0.58 | 0.57 |
Operating CF/Net income |
1.72 | 1.30 | 3.44 | 0.95 | 1.28 | 1.23 | 1.05 | 1.43 | 1.36 | 1.20 |
Capex/Depreciation |
(0.56) | (0.83) | (0.84) | (0.66) | (0.38) | (0.59) | (0.92) | (1.10) | (1.47) | (1.41) |
Interest Coverage |
8.54 | 10.22 | 12.05 | 12.72 | 10.85 | 16.63 | 19.26 | 14.21 | 15.50 | 13.21 |
| 10.98% | 15.06% | 6.72% | 22.99% | 14.95% | 23.58% | 23.45% | 22.24% | 21.95% | 20.62% | |
| 6.05% | 8.43% | 3.72% | 11.90% | 7.54% | 11.90% | 11.81% | 11.65% | 11.40% | 10.61% | |
ROIC |
9.96% | 12.74% | 13.70% | 11.40% | 9.25% | 12.87% | 14.48% | 12.07% | 11.75% | 11.55% |
Return on Tangible Assets |
13.88% | 18.67% | 9.03% | 54.67% | 25.74% | 39.86% | 41.56% | 32.18% | 33.55% | 30.52% |
Average Days of Receivables |
54.81 | 59.09 | 57.64 | 65.75 | 70.96 | 67.70 | 74.89 | 68.96 | 74.23 | 78.12 |
Research and Development Expense of Revenue |
7.83% | 7.63% | 7.88% | 7.82% | 9.27% | 6.98% | 6.82% | 7.04% | 7.36% | 6.55% |
Selling, General and Administrative Expense of Revenue |
29.82% | 27.97% | 28.27% | 28.28% | 28.02% | 25.62% | 23.90% | 23.91% | 24.09% | 24.60% |
Intangible Assets out of Total Assets |
0.38 | 0.35 | 0.41 | 0.50 | 0.46 | 0.46 | 0.45 | 0.41 | 0.42 | 0.39 |
Share Based Compensation of Revenue |
1.38% | 1.34% | 1.42% | 1.39% | 1.55% | 1.74% | 1.83% | 1.62% | 1.98% | 1.84% |
Graham Net Nets |
0.01 | 0.03 | (0.01) | (0.06) | (0.04) | (0.03) | (0.03) | (0.02) | (0.05) | (0.03) |
Graham Number |
20.33 | 26.83 | 17.90 | 33.96 | 28.75 | 39.84 | 40.95 | 43.45 | 45.08 | 49.46 |
Earnings Yield |
3.24% | 3.13% | 1.54% | 4.48% | 2.21% | 2.53% | 3.04% | 4.08% | 3.41% | 3.13% |
Free Cash Flow Yield |
4.60% | 3.25% | 4.38% | 3.64% | 2.47% | 2.71% | 2.46% | 4.84% | 3.63% | 2.78% |
Revenue per Share |
12.89 | 13.89 | 15.31 | 16.44 | 17.28 | 20.79 | 22.90 | 23.24 | 22.45 | 24.46 |
Operating CF per Share |
2.43 | 2.76 | 3.39 | 3.25 | 2.98 | 4.88 | 4.39 | 6.03 | 6.04 | 5.49 |
Capex per Share |
(0.43) | (0.55) | (0.55) | (0.50) | (0.38) | (0.62) | (0.97) | (1.01) | (1.30) | (1.43) |
Free Cash Flow per Share |
2.01 | 2.21 | 2.84 | 2.75 | 2.60 | 4.27 | 3.41 | 5.01 | 4.73 | 4.06 |
Cash per Share |
7.02 | 8.32 | 7.00 | 4.40 | 4.66 | 5.18 | 3.52 | 5.41 | 4.58 | 6.30 |
Shareholders Equity per Share |
13.02 | 15.02 | 14.24 | 15.12 | 15.77 | 17.73 | 17.74 | 19.88 | 20.34 | 23.74 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.02 | 15.02 | 14.24 | 15.12 | 15.77 | 17.73 | 17.74 | 19.88 | 20.34 | 23.74 |
Free Cash Flow |
654.00 | 713.00 | 911.00 | 865.00 | 803.00 | 1,297.00 | 1,021.00 | 1,474.00 | 1,373.00 | 1,152.00 |
Working Capital |
2,690.00 | 2,906.00 | 2,677.00 | 1,109.00 | 1,948.00 | 2,091.00 | 1,917.00 | 2,583.00 | 2,064.00 | 2,247.00 |
Capital Expenditures |
(139.00) | (176.00) | (176.00) | (156.00) | (118.00) | (188.00) | (291.00) | (298.00) | (378.00) | (407.00) |
Net Current Asset Value |
87.00 | 578.00 | (122.00) | (1,515.00) | (1,339.00) | (1,517.00) | (1,449.00) | (732.00) | (1,989.00) | (1,392.00) |
EV/EBIT |
22.47 | 26.06 | 22.51 | 25.71 | 39.44 | 36.30 | 26.60 | 23.36 | 26.75 | 28.96 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 | 0.06 |
Price to Operating Income |
23.10 | 27.14 | 23.01 | 25.28 | 38.44 | 35.45 | 25.57 | 22.51 | 25.40 | 28.10 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.39 | 0.28 | 0.26 | 0.28 | 0.36 | 0.34 | 0.29 | 0.21 | 0.14 | 0.14 |
Cash ROIC |
7.75% | 7.66% | 10.57% | 10.92% | 9.34% | 13.38% | 11.23% | 14.49% | 12.99% | 9.95% |
Accounts Receivable Turnover |
6.79 | 6.60 | 6.55 | 6.05 | 5.43 | 5.72 | 5.31 | 5.07 | 4.98 | 4.94 |
Accounts Payable Turnover |
7.48 | 7.38 | 6.93 | 6.80 | 7.07 | 7.28 | 6.09 | 6.75 | 6.21 | 5.96 |
Inventory Turnover |
3.73 | 3.74 | 3.68 | 3.58 | 3.58 | 3.76 | 3.35 | 3.26 | 2.97 | 3.31 |
Average Days of Payables |
46.79 | 53.70 | 55.55 | 54.80 | 51.64 | 55.90 | 67.72 | 45.30 | 66.25 | 62.95 |
Days of Inventory on Hand |
97.03 | 101.24 | 104.24 | 105.10 | 105.04 | 104.04 | 121.20 | 111.73 | 119.25 | 113.20 |
Average Receivables |
618.50 | 677.50 | 750.00 | 853.00 | 984.00 | 1,105.00 | 1,288.50 | 1,348.00 | 1,307.50 | 1,405.50 |
Average Payables |
268.00 | 281.00 | 322.50 | 347.00 | 354.00 | 400.00 | 513.00 | 499.00 | 479.00 | 555.00 |
Average Inventory |
537.00 | 554.00 | 606.50 | 658.50 | 699.50 | 775.00 | 934.00 | 1,034.50 | 1,001.50 | 998.50 |
Average Assets |
7,636.50 | 8,110.00 | 8,483.50 | 8,996.50 | 9,539.50 | 10,166.00 | 10,618.50 | 10,647.50 | 11,304.50 | 12,286.50 |
Average Common Equity |
4,208.00 | 4,540.50 | 4,703.00 | 4,659.50 | 4,810.50 | 5,131.00 | 5,347.00 | 5,575.00 | 5,871.50 | 6,319.50 |
Columns are period end dates